AHG (Akso Health Group) EBITDA per Share: $-0.00 (TTM As of Sep. 2025)


AHG Akso Health Group AHG
36 GF Score
Price $1.52
GF Value $0.47
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Akso Health Group EBITDA per Share?

Akso Health Group AHG +0.66% 36 EBITDA per Share is $-0.00 as of Sep. 2025. GuruFocus rates AHG with a GF Score™ of 36/100 and a GF Value™ of $0.47 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 105 Medical Distribution companies, Akso Health Group ranks better than 92.38% on this metric.

Akso Health Group's EBITDA per Share for the six months ended in Sep. 2025 was $0.00. Its EBITDA per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.00.

During the past 3 years, the average EBITDA per Share Growth Rate was 66.60% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 55.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Akso Health Group's EBITDA per Share or its related term are showing as below:

AHG' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -11.8   Med: 32   Max: 66.6
Current: 66.6

During the past 11 years, the highest 3-Year average EBITDA per Share Growth Rate of Akso Health Group was 66.60% per year. The lowest was -11.80% per year. And the median was 32.00% per year.

AHG's 3-Year EBITDA Growth Rate is ranked better than
92.38% of 105 companies
in the Medical Distribution industry
Industry Median: 5.5 vs AHG: 66.60

Akso Health Group's EBITDA for the six months ended in Sep. 2025 was $-0.21 Mil.

During the past 3 years, the average EBITDA Growth Rate was 17.90% per year. During the past 5 years, the average EBITDA Growth Rate was 25.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 11 years, the highest 3-Year average EBITDA Growth Rate of Akso Health Group was 31.40% per year. The lowest was -59.20% per year. And the median was 20.05% per year.


Akso Health Group  (NAS:AHG) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Akso Health Group EBITDA per Share Related Terms


Akso Health Group EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Akso Health Group's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akso Health Group EBITDA per Share Chart

Akso Health Group Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.13 -0.16 -0.62 -0.18 -0.01

Akso Health Group Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.04 -0.00 -0.00 0.00
AHG
36GF Score
Akso Health Group AHG
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akso Health Group EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Akso Health Group's EBITDA per Share for the fiscal year that ended in Mar. 2025 is calculated as

EBITDA per Share(A: Mar. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=-1.773/285.096
=-0.01

Akso Health Group's EBITDA per Share for the quarter that ended in Sep. 2025 is calculated as

EBITDA per Share(Q: Sep. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=-0.213/589.099
=-0.00

EBITDA per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of $-0.00 mean?
Akso Health Group (AHG) has a EBITDA per Share of $-0.00 as of Sep. 2025. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Akso Health Group and its competitors. According to the industry distribution chart, Akso Health Group ranks #8 out of 105 companies in the Medical Distribution industry, placing it in the top 7.6%.
Is Akso Health Group's EBITDA per Share too high?
Akso Health Group's current EBITDA per Share is $-0.00. Based on the distribution chart, Akso Health Group ranks #8 out of 105 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Akso Health Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Akso Health Group's EBITDA per Share compare to ACH and FOCL?
According to the Medical Distribution industry distribution chart, Akso Health Group ranks #8 out of 105 companies for EBITDA per Share. This places Akso Health Group in the top 8% of its industry — outperforming the majority of peers. The industry median EBITDA per Share is 5.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Medical Distribution company?
The median EBITDA per Share among Medical Distribution companies is 5.50, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Akso Health Group and its competitors. For the Medical Distribution industry, the median EBITDA per Share is 5.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akso Health Group's current EBITDA per Share is $-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akso Health Group stock overvalued right now?
Based on GuruFocus' analysis, Akso Health Group (AHG) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.47, compared to a current price of $1.52 — trading 223.4% above its estimated fair value. The current EBITDA per Share is $-0.00. Akso Health Group's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Akso Health Group (AHG), the current EBITDA per Share is $-0.00 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Akso Health Group (AHG) Overvalued in 2026?

Based on GuruFocus' analysis, Akso Health Group stock appears to be overvalued. The current stock price of $1.52 is trading 223.4% above its estimated GF Value™ of $0.47. GuruFocus considers Akso Health Group to be Significantly Overvalued.

Key valuation signals for AHG:

  • EBITDA per Share: $-0.00
  • GF Value™: $0.47 vs. price of $1.52 (223.4% above fair value)
  • GF Score™: 36/100 with 3 warning signs

No single metric tells the full story. See the AHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Akso Health Group Business Description

Address No. 44, Moscow Road, Qianwan Bonded Port Area, Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building, Qingdao Pilot Free Trade Zone, Shandong, CHN
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
36GF Score

Get the complete analysis for AHG

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.52
Price
$0.47
GF Value